Guangxi Cancer Hospital

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors	HER2-positive Advanced Solid Tumors	Recruiting	Early phase 1	2026-05-05		NCT05245058
HS-20089 in Patients With Ovarian Cancer and Endometrial Cancer	Adnexal Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, endocrine system disorder, endometrium neoplasm, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, primary peritoneal carcinoma, uterine disorder	Recruiting	Phase 2	2024-08-29		NCT06014190

Clinical trials